Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.
about
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Recent advances in T-cell engineering for use in immunotherapyNeoantigen: A Long March toward Cancer ImmunotherapyStable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System.IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.Peptide vaccines in cancer-old concept revisited.Integrated analysis of somatic mutations and immune microenvironment of multiple regions in breast cancers.Site-directed RNA editing by adenosine deaminase acting on RNA for correction of the genetic code in gene therapy.Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-α/β V(D)J recombinations correlates with PD-1 expression.Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer.Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells.Integrated analysis of somatic mutations and immune microenvironment in malignant pleural mesothelioma.WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy
P2860
Q28078539-E99325A6-1DC3-45AD-8B7F-0D45E947724FQ28080312-F9074F96-2F26-4A74-9368-98CAE77C3FD0Q36963359-998C6E5D-69B7-4674-A7A2-1496D1CC5A39Q37043492-BE736119-6894-4094-9BD4-2C97E25B963FQ37676297-4331E1CD-D809-4393-B4CC-7DBF831E1F1AQ38945576-C72258A8-B9AF-4306-9D34-CEF79CF13EDAQ39035351-C503A895-74E1-4FAF-89B5-D05156DA2874Q41790940-FDB64ED6-3F10-4977-8264-E38D95D848A3Q45872856-9ACDF60F-243B-4708-B2C9-390F8154346DQ47221163-548C03BF-BADA-4DD5-8C10-F399011266A2Q47952011-A7652820-FC2D-4592-A983-6BF9DA082AFBQ49483662-4A358ABA-946B-4FF7-BD66-9744C573EFDBQ53069347-F94B9F3D-5CBF-4330-A0D4-189D363230B6Q55011828-48440D7E-6E5F-4C3A-AE03-503F80F3E538Q55088639-D3217DD2-BEAB-44A1-AB53-BB8F865146ADQ57138889-7A0214FA-6CDD-4037-9008-6BC3A5CD6246
P2860
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Eradication of Large Solid Tum ...... ancer-Specific Point Mutation.
@en
Eradication of Large Solid Tum ...... ancer-Specific Point Mutation.
@nl
type
label
Eradication of Large Solid Tum ...... ancer-Specific Point Mutation.
@en
Eradication of Large Solid Tum ...... ancer-Specific Point Mutation.
@nl
prefLabel
Eradication of Large Solid Tum ...... ancer-Specific Point Mutation.
@en
Eradication of Large Solid Tum ...... ancer-Specific Point Mutation.
@nl
P2093
P2860
P1476
Eradication of Large Solid Tum ...... ancer-Specific Point Mutation.
@en
P2093
Ainhoa Arina
Boris Engels
Christian Idel
Hans Schreiber
Jaikumar Duraiswamy
Karin Schreiber
Kazuma Kiyotani
Matthias Leisegang
Poh Yin Yew
Wolfgang Uckert
P2860
P304
P356
10.1158/1078-0432.CCR-15-2361
P407
P577
2015-12-14T00:00:00Z